Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
  • Patient Engagement
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
Advance your patient engagement strategy

Discover new patient engagement possibilities with IQVIA insights, expertise, and technology-driven solutions.

Patient Engagement Overview
Patient Engagement Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Blog
IQVIA Consumer Health, ObvioHealth and Jovie USA Launch Innovative At-Home Trial to Bring First Goat Milk-Based Infant Formula to the US
The fully decentralized clinical trial was designed by IQVIA Consumer Health, ObvioHealth and Jovie USA, with guidance from the FDA, which is anticipated to fast-track approval for Jovie USA's goat milk-based formula.
Matt Stewart, Global Marketing Manager, IQVIA Consumer Health
Mar 29, 2023

IQVIA Consumer Health, in partnership with ObvioHealth, has launched a fully decentralized clinical trial with Jovie USA to bring the first FDA-approved goat milk-based infant formula to the United States. The innovative study design is the first of its kind for infant formula, allowing parents and their newborns to participate in the trial from their homes without the need for in-clinic visits.

Designed in collaboration with the FDA to increase the probability of regulatory success upon the completion of the trial, the study will evaluate whether babies fed Jovie’s goat milk-based formula show similar growth to babies who are fed cow milk-based formula or breast milk, the CDC’s growth standard.

To enable at-home participation, those taking part receive a scale and measuring devices and are trained during video calls by pediatric nurses on how to take the vital measurements essential to tracking healthy newborn growth. Nurses provide close oversight during measurements to ensure all is done correctly. The caregivers then use ObvioHealth’s app to report weekly measurements throughout the duration of the study.

The COACH (Clinical Oversight and Coordination Hub) team provides end-to-end, personalized assistance to caregivers via in-app messaging, phone, or video calls and remotely monitors trial data to ensure patient safety. The DCT platform is programmed to alert the COACH team of potential adverse events, such as an infant’s growth falling below the CDC threshold.

“Decentralized trials have been in high demand, yet their application in studies involving newborns has been notably limited thus far,” pointed out Dr Volker Spitzer, Vice-President, Global R&D/RWE Services, IQVIA Consumer Health. “Our collaboration with Jovie and ObvioHealth demonstrates the potential of such an innovative approach in accessing challenging-to-engage infant populations and their caregivers. We are thrilled to contribute to this initiative, which simplifies substantially parental involvement and eliminating the need for inconvenient clinic visits.”

In the U.S., four companies control approximately 90 percent of the infant formula market, an issue highlighted in 2022 at the peak of the U.S.’s formula shortage. Few other options are available to U.S. parents. Globally, goat milk infant formula is widely accepted, appreciated for its easier digestibility and nutrient absorption, and proven in clinical trials to be as safe and effective as cow milk formula and breastmilk.

“Parents in the U.S. who can’t or don’t want to breastfeed deserve more options,” said Jan van Marwijk Kooij, CEO of Jovie USA. “We are excited to have the opportunity to bring the first goat milk-based infant formula to the U.S. market, and we believe this trial will prove to regulators and parents alike that goat milk-based infant formula is an excellent choice.”

Related solutions

Industry Segments

See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.

Contact Us